Literature DB >> 26384138

Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity.

F-F Chen1, Y Liu1, F Wang1, X-J Pang1, C-D Zhu1, M Xu1, W Yu1, X-J Li1,2.   

Abstract

The inhibitor of DNA-binding/differentiation 3 (Id3) protein is a helix-loop-helix transcription factor and may have an important role in cell proliferation and differentiation. This study was to evaluate the effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity. Short interference RNA suppression of Id3 (miRId3) in A549 cells was used to investigate the functional role(s) of Id3. Next, we used in vitro wound-healing assay and trans-well assay to study the effects of overexpressed Id3 on migration and invasion of A549 cells. Furthermore, to explore the influence of overexpressed Id3 on in vivo tumorigenesis, adenoviruses containing Id3 gene (Ad-Id3) and empty vector (Ad-LacZ) were generated. Co-transfection of pcDNA/miRId3 and pEGFP/Id3 into A549 cells reversed the Id3-induced cell proliferation inhibition and apoptosis. Upon Id3 transfection, A549 cells displayed decreased migratory and invasive capabilities, however, co-transfection of miRId3 and Id3 into A549 cells reversed the Id3-induced inhibitions of migratory and invasive capabilities. Three groups of nude mice were inoculated with Ad-LacZ, Ad-Id3 transfectants and untransfected A549 cells, respectively. Twenty-eight days after inoculation, tumors induced by Ad-Id3 transfectants grew much more slowly compared with Ad-LacZ transfectants and control group. This study provides for the first time both in vitro and in vivo proofs that forced expression of Id3 in lung adenocarcinoma cells reduces tumor growth rate and may be a potential target for tumor suppression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26384138     DOI: 10.1038/cgt.2015.38

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  35 in total

1.  Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells.

Authors:  Ming-Tat Ling; Xianghong Wang; Xue-Song Ouyang; Kexin Xu; Sai-Wah Tsao; Yong-Chuan Wong
Journal:  Oncogene       Date:  2003-07-17       Impact factor: 9.867

2.  Id3 induces a caspase-3- and -9-dependent apoptosis and mediates UVB sensitization of HPV16 E6/7 immortalized human keratinocytes.

Authors:  C M Simbulan-Rosenthal; A Daher; V Trabosh; W-C Chen; D Gerstel; E Soeda; D S Rosenthal
Journal:  Oncogene       Date:  2006-01-30       Impact factor: 9.867

3.  UVB upregulates the bax promoter in immortalized human keratinocytes via ROS induction of Id3.

Authors:  Valerie Anne Trabosh; Ahmad Daher; Kyle A Divito; Karishma Amin; Cynthia M Simbulan-Rosenthal; Dean S Rosenthal
Journal:  Exp Dermatol       Date:  2008-10-23       Impact factor: 3.960

4.  Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.

Authors:  Yasutaka Shuno; Nelson H Tsuno; Yurai Okaji; Takeshi Tsuchiya; Daisuke Sakurai; Takeshi Nishikawa; Naoyuki Yoshikawa; Kazuhito Sasaki; Kumiko Hongo; Giichiro Tsurita; Eiji Sunami; Joji Kitayama; Katsushi Tokunaga; Koki Takahashi; Hirokazu Nagawa
Journal:  J Surg Res       Date:  2008-11-29       Impact factor: 2.192

5.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

6.  Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta.

Authors:  B L Kee; R R Rivera; C Murre
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

7.  Developmental ablation of Id1 and Id3 genes in the vasculature leads to postnatal cardiac phenotypes.

Authors:  Qingshi Zhao; Amanda J Beck; Joseph M Vitale; Joel S Schneider; Shumin Gao; Corey Chang; Genie Elson; Samuel J Leibovich; Ji Yeon Park; Bin Tian; Hyung-song Nam; Diego Fraidenraich
Journal:  Dev Biol       Date:  2010-10-23       Impact factor: 3.582

8.  Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.

Authors:  Electron Kebebew; Miao Peng; Patrick A Treseler; Orlo H Clark; Quan-Yang Duh; David Ginzinger; Richard Miner
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

9.  Increased expression of Id1 and Id3 promotes tumorigenicity by enhancing angiogenesis and suppressing apoptosis in small cell lung cancer.

Authors:  Danqing Chen; Shiva S Forootan; John R Gosney; Farzad S Forootan; Youqiang Ke
Journal:  Genes Cancer       Date:  2014-05

10.  Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas.

Authors:  J M Arnold; S C Mok; D Purdie; G Chenevix-Trench
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

View more
  6 in total

1.  Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts.

Authors:  Jeffrey J Quinn; Matthew G Jones; Ross A Okimoto; Shigeki Nanjo; Michelle M Chan; Nir Yosef; Trever G Bivona; Jonathan S Weissman
Journal:  Science       Date:  2021-01-21       Impact factor: 47.728

2.  Characterization and bioactivity of self-assembled anti-angiogenic chondroitin sulfate-ES2-AF nanoparticle conjugate.

Authors:  Liang Xing; Feng Sun; Zhendong Wang; Yan Li; Zhifang Yang; Fengshan Wang; Guangxi Zhai; Haining Tan
Journal:  Int J Nanomedicine       Date:  2019-04-10

3.  EGF stimulates human trophoblast cell invasion by downregulating ID3-mediated KISS1 expression.

Authors:  Lanlan Fang; Yibo Gao; Zhen Wang; Yuxi Li; Yang Yan; Ze Wu; Jung-Chien Cheng; Ying-Pu Sun
Journal:  Cell Commun Signal       Date:  2021-10-07       Impact factor: 5.712

4.  Integrative Genomics Implicates EGFR as a Downstream Mediator in NKX2-1 Amplified Non-Small Cell Lung Cancer.

Authors:  Nicole Clarke; Jewison Biscocho; Kevin A Kwei; Jean M Davidson; Sushmita Sridhar; Xue Gong; Jonathan R Pollack
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

5.  Long Non-Coding RNA and mRNA Profiling in Early-Stage Bovine Embryos Treated with Glutathione.

Authors:  Qinqin Guo; Lixin Cui; Weijun Sun; Feng Li; Haisheng Hao; Xueming Zhao; Huabin Zhu; Weihua Du
Journal:  Antioxidants (Basel)       Date:  2020-05-08

6.  Inhibitor of DNA binding 3 reverses cisplatin resistance in human lung adenocarcinoma cells by regulating the PI3K/Akt pathway.

Authors:  Fang-Fang Chen; Xing Lv; Qin-Fei Zhao; Yu-Zhong Xu; Shu-Sheng Song; Wei Yu; Xiao-Jun Li
Journal:  Oncol Lett       Date:  2018-05-31       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.